The high cost of prescription drugs has recently made headlines, evidenced by price-gouging schemes that cause drug prices to skyrocket 5,000% (as in the case with the infamous Martin Shkreli and the drug Daraprim) or Mylan’s more recent price hike on EpiPen’s to over $600 for a two-pack.

What’s often left out of these stories, however, is how the federal government helped the pharmaceutical industry have this kind …read more

Source: Health Impact News